celecoxib has been researched along with mavatrep in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brandt, MR; Calvo, RR; Cheung, W; Dax, SL; Finley, M; Flores, CM; Hutchinson, T; Lee, YK; Liu, J; Liu, Y; Lubin, ML; Parsons, WH; Patel, S; Player, MR; Qin, N; Stone, D; Youngman, MA; Zhang, SP | 1 |
1 other study(ies) available for celecoxib and mavatrep
Article | Year |
---|---|
Benzo[d]imidazole Transient Receptor Potential Vanilloid 1 Antagonists for the Treatment of Pain: Discovery of trans-2-(2-{2-[2-(4-Trifluoromethyl-phenyl)-vinyl]-1H-benzimidazol-5-yl}-phenyl)-propan-2-ol (Mavatrep).
Topics: Analgesics; Animals; Benzimidazoles; Biological Availability; Carrageenan; Dogs; Freund's Adjuvant; Haplorhini; HEK293 Cells; Hot Temperature; Humans; Hyperalgesia; Inflammation; Male; Mice; Microsomes, Liver; Pain; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; TRPV Cation Channels | 2015 |